News Article | May 22, 2017
- Enterprise Ethereum Alliance (EEA), a newly formed enterprise collaboration focused on Ethereum blockchain technology, is pleased to announce the addition of over 86 new companies to its membership with many continuing to onboard and be announced in the upcoming months. Comprised of the most advanced enterprises and startup blockchain innovators, EEA is designed to build, promote, and broadly support Ethereum-based technology best practices, standards, and a reference architecture, EntEth 1.0. The new members of EEA include Access, Adapt Forward, Alchemy Limited, AlphaPoint, Antony Welfare, Aquarius Capital Management, AutoBoard Systems, Axcent LLC, Bancor, BigchainDB, Blk Technologies, Blockchain Hub Limited, BlockCypher, Brian Ray, Broadridge, CareChain, CCA, Clause, Clearmatics Technologies, Clozer Technologies, CoinFund, Coinplug, ConsenLabs, Consensus Base, Couger, CryptoMKT, CYPHA GmbH, Dapps.ai, Datarella, DeliverThat, De Cooperatieve Rabobank U.A, Deloitte, The Depository Trust & Clearing Corporation (DTCC), DigixGlobal, Dinosaur Dog, ElectricChain, Elevondata Labs Inc., Etherisc, Fundacion CTIC Centro Tecnologico, Gem, Global Consent Limited, Global Trade Guardian - LexEcon Consulting Group, Hashed Health, Hijro, Illinois Department of Financial and Professional Regulation, Infosys, InGauge Trading Technologies Inc., Ian Pilon, Infrachain Asbl, Intelligent’er Re’Development, ING, iPaynow, Jiangsu Huaxin Blockchain Research Institute, Kaula, Ledger, Libra, Melonport, Merck KGaA, Darmstadt, Germany, MME, Mitsubishi UFJ Financial Group, Model Communities Association, Musicoin, National Bank of Canada, Noah Perius, Nordic Alliance, NXN, Parkview Ventures, Qingxin Technology, Red Chalk Group, Samsung SDS, San Francisco Stock Exchange, Smart Contract Japan, SmartU Electronics Trading L.L.C, State Street Emerging Technologies Center, Synechron, Taishin Financial Holdings, Taiwan FinTech Association, Tecnalia Research & Innovation, Toyota Research Institute, TraderLynk Ltd, Trust Stamp, UNLP, Utocat, Vanbex Group, Wall Street Blockchain Alliance, and Zerocoin Electric Coin Company. The Enterprise Ethereum Alliance (EEA) was formed earlier this year, seeking to evolve Ethereum so that is can serve as an enterprise-grade technology. EEA’s research and development is focused on privacy, confidentiality, scalability, and security. EEA is also investigating hybrid architectures that span both permissioned and public Ethereum networks as well as industry specific application layer working groups. Julio Faura, chairman of EEA and head of blockchain r&d at Santander expressed, “The enthusiasm around EEA is remarkable. Our new members come from varying industries such as pharma, mobile, banking, automotive, management consulting, and hardware as well as the startup community driving innovation. It’s great to see everyone come together and build the next generation of our economy on Ethereum blockchain solutions.” EEA will collectively develop industry standards and facilitate open source collaboration with its member base and is open to any members of the Ethereum community who wish to participate. This collaborative framework will enable the mass adoption at a depth and breadth otherwise unachievable in individual corporate silos and provide insight to the future of scalability, privacy, and confidentiality of the public Ethereum permissionless network. For additional information about joining EEA, please reach out to [email protected]
News Article | May 18, 2017
Zensar Technologies, a leading provider of digital solutions, software and infrastructure services, announced the launch of its Blockchain Enablement Framework. Zensar’s Blockchain enablement framework is designed to address challenges in the context of financial transactions undertaken using digital platforms. It follows a unique business-led consulting approach, bringing Zensar’s expertise in having managed complex transactions for global financial companies to the fore. Enterprises can look forward to enhanced business benefit realization from the ever-increasing digital financial transactions. Additionally, Zensar’s framework incorporates efficiency as well as transparency enabling enterprises to benefit from the simplified approach. Sandeep Kishore, Chief Executive Officer and Managing Director, Zensar Technologies commented, “It is our endeavor to introduce solutions that offer clear Return on Digital™ benefits to global enterprises that are looking for success from their digital transformation initiatives. Our Blockchain framework aims to bring in the business-led consulting approach to a critical area for any financial or non-financial company looking to resolve real business problems. The team is well-versed working with this path-breaking technology led offering to bring about significant outcomes for our customers worldwide.” Gartner Research says, ‘Blockchain is gaining traction because it holds the promise to transform industry operating models. It is also one example of an enabling technology of the platform revolution trend, one of the three trends along with transparently immersive experiences and perceptual smart machine age highlighted in the Gartner Hype Cycle for Emerging Technologies 2016’. * According to Prameela Kalive, EVP and Head, Applications Business Solutions, “Zensar’s Blockchain framework is built with our vast experience in having helped global companies benefit from secure, flexible and effective solutions. We are confident that our customers will derive value from our Blockchain IPs and solution accelerators for both, financial and non-financial applications.” On implementing the Zensar Blockchain Framework, enterprises can achieve measurable returns on their digital investments as follows: *Source: Gartner, Smarter With Gartner, “3 Trends Appear in the Gartner Hype Cycle for Emerging Technologies, 2016”, http://www.gartner.com/smarterwithgartner/3-trends-appear-in-the-gartner-hype-cycle-for-emerging-technologies-2016/ About Zensar (http://www.zensar.com) Zensar is a leading digital solutions and technology services company that specializes in partnering with global organizations across industries on their Digital Transformation journey. A technology partner of choice, backed by a strong track record of innovation; credible investment in Digital solutions; and unwavering commitment to client success, Zensar’ s comprehensive range of digital and technology services and solutions enables its clients achieve new thresholds of business performance. Zensar, with its experience in delivering excellence and superior client satisfaction through myriad technology solutions, is uniquely positioned to help its clients surpass challenges they face running their existing business most efficiently, helping in their legacy transformation, and planning for business expansion and growth through innovative and digital ways. Follow Zensar via: Zensar Blog: http://www.zensar.com/blogs Twitter: https://twitter.com/Zensar LinkedIn: https://www.linkedin.com/company/zensar-technologies Facebook: https://www.facebook.com/Zensar Catch our refreshed new website at: http://www.zensar.com About RPG Enterprises (http://www.rpggroup.com) Mumbai headquartered RPG Enterprises is one of India's largest industrial conglomerates. With over 15 companies in its fold, the group has a strong presence across core business sectors such as Infrastructure, Tyre, IT and Specialty. Established in 1979, RPG Enterprises is one of India’s fastest growing business groups with a turnover in excess of Rs 21,000 crore. Safe Harbor Certain statements in this release concerning our future growth prospects are forward-looking statements which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorised use of our intellectual property and general economic conditions affecting our industry. The Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.
News Article | May 18, 2017
PossibleNOW, the leading provider of customer engagement and enterprise preference management solutions, today announced its inclusion in a report on marketing technology by Forrester Research, an independent global technology and market research company. Entitled “The Top Emerging Technologies for B2C Marketers,” the April 2017 report identifies Enterprise Preference Management (EPM) as a new technology that marketers must adopt and lists PossibleNOW as an example of an EPM vendor. The report, co-authored by Vice-President and Principal Analyst Joe Stanhope and Vice President and Research Director Mary Pilecki, contends that EPM is marketing’s most overlooked tool and that it fuels customer understanding. “Enterprise preference management builds customers’ trust by providing customers with meaningful marketing choices and some control over how a brand communicates with them,” writes Stanhope and Pilecki. “We agree with Forrester’s research — preference management builds customer trust,” says Scott Frey, President and CEO of PossibleNOW. “At the same time, it helps companies earn consent to communicate and manage that consent as it evolves over time, critical functions for any business and essential for those with EU customers under the new GDPR rules.” The report states that marketers that have jumped the chasm from the digital world to the post-digital world need technologies that help them be “human, helpful and handy.” It also states that EPM “lets marketers validate their assumptions” and “capture preferences that are otherwise difficult or impossible to infer.” MyPreferences, PossibleNOW's enterprise preference management solution, enables prospects and customers to express and revoke their preferences at a granular level for maximum choice and drives adoption across the enterprise at every customer touchpoint. About PossibleNOW PossibleNOW leverages powerful technology and industry-leading expertise to enable companies to listen to customers, remember what they like and dislike and respond in useful, personalized ways. It’s enterprise preference management platform, MyPreferences®, collects customer and prospect preferences, stores them safely and makes them available to any other system or application in the enterprise. PossibleNOW strategic services experts identify opportunities, plan technology deployments, design preference collection interfaces and position clients for a win. PossibleNOW is purpose-built to help large, complex organizations gain control over communications, mitigate compliance risk and reduce marketing expenses while improving customer experience and loyalty. For more information, call (800) 585-4888, email info(at)possiblenow(dot)com or visit http://www.possiblenow.com.
News Article | May 22, 2017
"We continually look for ways to help our partners engage with their customers, drive sales and improve brand perception" said Mark Singer, Regional Senior Vice President of Asia at InComm. "This is another example of how working with our key partners we delivered a program under tight timelines to help drive sales with a unique promotional campaign." "We appreciate the responsiveness and flexibility of InComm's promotional platform and team" said Jacqueline Chiu, Head of Network Business from Sony Interactive Entertainment HK Ltd (SIEH). "Partnering with such a reputable and resourceful company as InComm will help us to significantly grow the PlayStation®Plus and PlayStation®Store business with and for our retail partners." InComm's on-going investment in promotional tools positions the company to continue to transform how gift cards are purchased by tying together physical and digital channels to deliver an engaging experience. Karl Denzer, Senior Vice President of Emerging Technologies at InComm adds "We have executed similar cross-channel programs in Japan, Australia, the US, UK, The Netherlands and Italy, and we continually look for ways to codify best practices and enhance the process to drive value for our partners". About InComm Leveraging deep integrations into retailers' point-of-sale systems, InComm provides connectivity to a variety of service providers that allow consumers to conduct everyday business at more than 500,000 points of retail distribution. Whether those consumers are activating prepaid products, paying bills, enjoying real-time discounts through a membership card, purchasing digital goods in-store or adding funds to an online account, InComm is there to provide unique gift-gifting opportunities, cater to on-the-go shoppers, deliver added value through loyalty programs and serve cash-based consumers. With 206 global patents, InComm is headquartered in Atlanta with a presence in more than 30 countries. Learn more at www.incomm.com or connect with us on www.twitter.com/incomm, www.facebook.com/incomm, www.linkedin.com/company/incomm or www.incomm.com/blog. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/incomm-partners-with-sony-to-deliver-leading-edge-promotional-tools-in-hong-kong-300461368.html
News Article | May 23, 2017
HONG KONG--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) announced that LumenLab, its Singapore based innovation center has won Celent’s Model Insurer Asia 2017 in the category of “Innovation and Emerging Technologies” at an awards event held today in Singapore. Established in 2015, LumenLab is MetLife’s global innovation center focused on digital disruption based on customer insights. In the category of “Innovation and Emerging Technologies”, LumenLab is recognised for the development and application of new technologies and for generating new business models. LumenLab has incubated 12 projects spanning technologies such as artificial intelligence, blockchain, and virtual reality. In addition, LumenLab underscores MetLife’s commitment to embedding an innovation culture and supporting ideas that culminate in a better customer experience. Over 400 MetLife employees have taken part in workshops, bootcamps and leadership programs to “test and learn” and fast track delivery of solutions that will better meet the needs of the customer. “MetLife is delighted to be recognized as a leader in Innovation in our industry” said Zia Zaman, LumenLab CEO and Chief Innovation Officer of MetLife Asia. “There is so much opportunity to benefit customers across Asia by reimagining insurance. Shifting the mindset of the industry to innovate more is essential. We would like to thank the panel of judges and Celent for encouraging innovation and for recognizing LumenLab.” Hosted by Celent, a global research and consulting firm focused on the application of information technology in the financial services industry, the annual Model Insurer Award recognizes insurance firms that effectively utilize technology as a means to foster investment in innovation. Model Insurer is awarded for best practices of technology usage in different areas critical to success in insurance, and is the main award an insurer can win from Celent. Nominations are submitted by insurance companies and technology vendors, and undergo a rigorous evaluation process. Submissions are evaluated on three criteria: demonstrable business benefits; degree of innovation; technology or implementation excellence. The award for Innovation and Emerging Technologies recognizes projects such as the expansion into previously untapped markets due to technology; the use of technologies not previously used in the insurance industry; or the development of an innovation culture within an IT organization. This category also includes Insurtech initiatives which are rapidly expanding development and application of new technologies and operating models with the aim to fundamentally change current business models, financial models, and/or industry ecosystem. MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ("MetLife"), is one of the largest life insurance companies in the world. Founded in 1868, MetLife is a global provider of life insurance, annuities, employee benefits and asset management. Serving approximately 100 million customers, MetLife has operations in nearly 50 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com. As MetLife's pioneers for disruptive innovation, LumenLab is charging ahead to create new businesses in health, wealth and retirement. Lumen, a measure of light, symbolises our commitment to illuminating a new path for solving the problems that the people of Asia face today. Through our focus on building new products and services grounded in technology and data, we aim to help people achieve richer and more fulfilling lives. For more information, visit www.lumenlab.sg.
News Article | March 1, 2017
Dublin, March 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Industrial IoT and 5G: Emerging Technologies, Solutions, Market Outlook and Forecasts" report to their offering. Unlike LTE /4G, the fifth generation (5G) of wireless will represent a purpose-built technology, designed and engineered to facilitate connected devices as well as automation systems. In many ways, 5G will be a facilitator and an accelerator of the next industrial revolution, often referred to as Industry 4.0. There is a need to look beyond smart factories, intelligent products and services towards enterprise as a whole and the unique benefits of high capacity urban wireless applications. One of the important issues to consider with 5G planning for IIoT is that success will largely be dependent on allocation of required spectrum since it will dictate the performance of the system.- There will also be a need for specific SLA allocations for 5G in IIoT such as factory cell automation requirements for guaranteed as well as ultra-reliable service. This research evaluates the technologies, solutions, and market outlook for 5G in the IIoT segment. The report includes forecasting through 2025 for many key areas. Target Audience: - Robotics companies - Wireless service providers - 5G infrastructure suppliers - Internet of Things companies - Wireless device manufacturers - Enterprise and industrial verticals Key Topics Covered: 1 Introduction 1.1 Why Industrial IoT and 5G? 1.2 Industrial IoT Platforms 1.3 Relationship between Industrial IoT and 5G 1.4 Industrial IoT: A View into the Period 2016 to 2020 1.5 5G as Key Enabler for IIoT Initiatives 1.6 5G Responsiveness to IIoT 1.7 Potential Contribution of Proprietary Platform 1.8 5G and Industrial Automation 1.9 5G to Enable Wireless IIoT Automation 1.10 5G for Industrial Internet Components 1.11 Role of Industrial Internet in IIoT Automation 1.12 Role of Mobile Edge Computing in IIoT and 5G 1.13 Role of Smart Grid in IIoT and 5G 1.14 Role of LPWAN Technology to IIoT 1.15 5G to Create News Business Model for IIoT 1.16 IIoT Security 1.17 IIoT and 5G: Where is the Money? 1.18 Virtual Reality, IIoT, and 5G 1.19 IIoT 5G Stakeholder Analysis 1.19.1 Equipment Manufacturer 1.19.2 Connectivity Solution Providers 1.19.3 Proprietary Platform and IIoT Application Providers 1.19.4 Data Analytics Providers 1.19.5 Professional Service Providers 1.19.6 Enterprise 1.19.7 End Users 2 IIoT 5G Application Scenarios 2.1 Maritime Use Case 2.1.1 Optimizing Route 2.1.2 Tracking Assets 2.1.3 Monitoring Equipment Remotely and Saving Costs 2.2 Oil and Gas Sector 2.3 Manufacturing Use Case 2.4 Mobile Cloud Robotics 2.5 Precision Agriculture 2.5.1 OnFarm Solution 2.5.2 AT&T, Telefonica, and Verizon to Precision Agriculture 2.6 City Waste Management 2.6.1 Urbiotica Case 2.6.2 Enevo 2.7 Food Waste Management 2.7.1 Maersk Line Remote Container Management 2.8 Smart Buildings 2.8.1 Honeywell Intelligent System to Olympics Stadium 2.9 Road Congestion Management 2.10 Efficient Energy Management 2.11 Enterprise Asset Management 2.12 Healthcare Applications 2.13 Shipping Automation 2.14 Autonomous Driving 2.15 Water Management 2.16 Aviation Management 3 IIoT 5G Market Forecasts 3.1 Global Forecasts 2020 - 2025 3.1.1 IIoT 5G Automation Market Value 184.108.40.206 Market by Segment 220.127.116.11.1 Hardware & Equipment Market by Types of Device 18.104.22.168 Market by Industry Verticals 22.214.171.124 Market by Technology Application 3.1.2 Wireless IIoT 5G Device Deployments 126.96.36.199 Deployment by Device Type 188.8.131.52 Deployment by Industry Vertical 3.2 Regional Forecasts 2020 - 2025 3.2.1 Market Value by Region 3.2.2 Market Value by Leading Countries 3.2.3 Deployment by Region 3.2.4 Deployment by Leading Countries 3.2.5 Europe Market Forecasts 184.108.40.206 Market Value by Segment, Devices, Industry Vertical, & Technology Application 220.127.116.11 Deployment Base by Devices & Industry Vertical 3.2.6 North America Market Forecasts 18.104.22.168 Market Value by Segment, Devices, Industry Vertical & Technology Application 22.214.171.124 Deployment Base by Devices & Industry Vertical 3.2.7 APAC Market Forecasts 126.96.36.199 Market Value by Segment, Devices, Industry Vertical & Technology Application 188.8.131.52 Deployment Base by Devices & Industry Vertical 4 Industrial IoT 5G Platforms, Solutions, and Initiatives 4.1 Time Sensitive Networking 4.2 General Electric 4.2.1 GE Predix 4.2.2 GE Predictivity 4.2.3 GE Partnership 184.108.40.206 Microsoft and GE 220.127.116.11 AT&T and GE 18.104.22.168 Cisco and GE Energy 22.214.171.124 Intel and GE 126.96.36.199 NTT DoCoMo and GE 188.8.131.52 HP and GE 184.108.40.206 BP and GE Oil & Gas 220.127.116.11 Paradigm and GE Oil & Gas 4.3 Qualcomm 4.3.1 LTE IoT Connectivity Platform creating Path for 5G 4.3.2 LTE Modem Solutions 4.4 Aware360 4.4.1 Real Time Monitoring Solution 4.4.2 Aware360 with Gemalto for IIoT Connectivity & Analytics 4.5 KAA 4.6 XILINX 4.6.1 Xilinx to Collaborate IIC for Common IIoT Framework 4.7 AT&T 4.7.1 AT&T M2M Solution 18.104.22.168 AT&T alliance with GE 4.7.2 AT&T M2X Solution 4.7.3 AT&T vEPC Network and Domain 2.0 4.7.4 AT&T 5G Trial and IIoT 4.8 Bosch 4.8.1 Bosch IoT Suit 4.8.2 Bosch IoT Cloud 4.8.3 Bosch Connected Devices and Solutions GmbH (BCDS) 4.9 Cisco System 4.9.1 Cisco IoT System 4.9.2 Cisco Industrial Networking Solutions for IoT 4.9.3 Cisco Embedded Networking Solution 4.9.4 Cisco Security Solution 4.9.5 Application Enablement Platform 4.9.6 Cisco IoT Analytics 4.9.7 Cisco Fog Computing 4.9.8 Cisco's Acquisition of Jasper 4.10 Echelon Corporation 4.10.1 Echelon IzoT Platform 22.214.171.124 IzoT Enabled FT 6050 Chip 4.10.2 Industrial Control Networking Technologies 4.10.3 Xicato Demonstrate Intelligent Platform with Echelon 4.11 Object Management Group 4.11.1 OMG Data Distribution Service 4.11.2 Dependability Assurance Framework for Safety-Sensitive Consumer Devices 4.11.3 Threat Modeling 4.11.4 Structured Assurance Case Metamodel 4.11.5 Unified Component Model for Distributed, Real-Time and Embedded Systems 4.11.6 Automated Quality Characteristic Measures 4.11.7 Interaction Flow Modeling Language 4.11.8 OMG to Manage the Industrial Internet Consortium 4.11.9 Automated Source Code Based Security Measure 4.11.10 Oil and Gas Risk Management 4.12 Real Time Innovation 4.12.1 RTI Connext DDS 4.12.2 RTI IoT FastTrax Program 4.12.3 RTI to Support IIC Connected Care Testbed 4.12.4 RTI Alliance with National Instruments 4.13 Google 4.13.1 Brillo and Weave 4.13.2 Google Cloud Platform 4.13.3 Google Glass in Telemedicine with CrowdOptic 4.14 Omron Corporation 4.15 BlackBerry 4.15.1 BlackBerry IoT Platform 126.96.36.199 QNX Software 4.16 Rockwell Automation 4.17 Honeywell International 4.17.1 Honeywell Process Solution 4.17.2 Honeywell Uniformance IIoT Suite 4.18 Fujitsu America 4.18.1 GR AWARE Platform 4.18.2 iMotion Edgeware Platform 4.18.3 GYUHO SaaS 4.18.4 UBIQUITOUSWARE Device 4.18.5 CRATUS and Fujitsu 4.18.6 Fujitsu Connected Enterprise Solution with SAP 5 Conclusions and Recommendations 5.1 Success Factors for IIoT in 5G 5.1.1 Complex Ecosystem Management 5.1.2 Accuracy in Analysis and Quantification 5.1.3 Spectrum Management 5.1.4 Building Data Trust Companies Mentioned - AT&T - Aware360 - BlackBerry - Bosch - Cisco System - Echelon Corporation - Fujitsu America - General Electric - Google - Honeywell International - KAA - Object Management Group - Omron Corporation - Qualcomm - Real Time Innovation - Rockwell Automation - XILINX For more information about this report visit http://www.researchandmarkets.com/research/t589m8/industrial_iot
News Article | February 27, 2017
Research and Markets has announced the addition of the "Sealants and Sealant Applicators: Technologies and Global Markets" report to their offering. The report has been prepared in a simple format that can be easily understood with a number of tables and charts/figures. The scope of the report includes a detailed study of the global and regional markets for various types of sealants, with the reasons given for variations in the growth of the industry in certain regions. The report also studies the different types of equipment used for applying sealants and the global and regional market for these. Report Includes: - An overview of the global sealants and sealant applications market. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. - Information on product life styles and technology life styles (TLC) of various types of sealants and methods employed by manufacturers and users in maintaining an ecological balance. - Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities. - A breakdown of not only global but regional markets for sealants, with the purpose of locating newer markets and expanding the present market position for various types of sealants. - Profiles of major players in the industry. The following categories of sealants are covered in this report: - Silicone sealants. - Polyurethane (PUR) sealants. - Acrylic sealants. - Silyl-modified polymer sealants. - Butyl sealants. - Polysulfide sealants. - Other sealants. For this report, sealant equipment has been generally classified as follows: - Unloading equipment. - Dispensing equipment. - Application equipment. - Auxiliary equipment. Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing The Study - Intended Audience - Scope Of Report - Information Sources And Methodology 2: Summary - Major Markets For Sealants 3: Overview - Definition Of The Industry - Industry Concepts - Importance Of The Industry - Life Cycle Assessment Of Sealants - Technology Life Cycle - Early History Of Sealants/Adhesives - Recent History Of Sealants/Adhesives - Development Of The Sealants Industry - Government Regulations - Environmental Protection - Sealants In Industrial Use - Sealants In Home Use - Industrial And Consumer Safety 4: Market For Sealants By Technology - Overview - Global Market For Sealants Based On Technology - Global Market For Sealants Based On Product Category - Regional Markets For Sealants 5: Global Market For Sealant Applications - Overview Of Sealant Applications - Global Market For Sealants In Various Applications 6: Sealant Application Equipment - Market For Sealant Application Equipment 7: Technology - Overview - Sealant Technologies - Classification Of Sealants - Composition Of Sealants - Rheology Of Sealant Formulations - Raw Materials For Sealants - Emerging Technologies In Sealants - Nanoengineered Sealants - Significance Of Patents - Standards 8: Industry Structure And Competitive Analysis - Overview - Structure Of Sealant Industry - Present And Future Market For Sealants - Innovations In The Sealants Market - Requirements Of The Adhesives And Sealants Industry - Driving Forces In The Sealants Market - Analysis Of Competition Within The Sealants Industry - Mergers And Acquisitions - International Aspects - Research And Development - New Products Resulting From R&D 9: Profiles Of Major Manufacturers Of Sealants And Sealant Application Equipment - 3M Co. - Acoustical Surfaces - ADCO Products Inc. - Albion Engineering Co. - American Biltrite Inc. - APV Engineered Coatings - Aremco Products Inc. - Ashby Cross Co. Inc. - Ashland Inc. - Avery Dennison Corp. - Bdtronic Gmbh - Beardow & Adams (Adhesives) Ltd. - Bison International B.V. - Bostik S.A. - Chemence Ltd. - Cryolife - DAP Products Inc. - Designetics Inc. - DOW Corning Corp. - Dymax Corp. - Elmer's Products Inc. - Emseal Joint Systems Ltd. - Ems-Chemie Holding Ag - Everkem Diversified Products - Exel Industries - Fishman Corp. - Forbo International. S.A. - Foshan Maydos Chemical Co. Ltd. - Franklin International Inc. - Glenmar Technology - Glue Dots International - Graco Inc. - H.B. Fuller Co. - Henkel Ag & Co Kgaa - Hernon Manufacturing Inc. - Hexion Specialty Chemicals Inc. - Hodgson Sealants (Holdings) Ltd. - Huntsman Corp. - Hutchinson S.A. - IGS Industries - Illinois Tool Works Inc. - ITW Performance Polymers & Fluids China - Konishi Co. Ltd. - Lifebond Ltd. - Life Industries Corp. - Lincoln Industrial Corp. - Lord Corp. - Mapei SPA - Master Bond Inc. - Momentive Performance Materials Inc. - Mccoy Soudal Sealants Adhesive & Foams Pvt. Ltd. - National Starch & Chemical Co. - Ninghai Dingcheng Adhesive Co. Ltd. - Nordson Asymtek K.K. - Nordson Corp. - Nordson EFD Llc - Pidilite Industries Ltd. - Quilosa Industrias Químicas Löwenberg S.L. - Rohm And Haas Co. - Royal Adhesives & Sealants - RPM International Inc. - SCA Schucker GMBH & Co. KG - Scheugenpflug AG - Scigrip Americas - Sealant Equipment & Engineering Inc. - Shurtape Technologies Llc - SIKA AG - Super Glue Corp. - Techadhesion Systems Ltd. - TESA SE - Thermal Innovations Corp. - Threebond Holdings Co. Ltd. - Total S.A. - Universal Sealants (U.K.) Ltd. - Vagnone & Boeri S.R.L - Valco Melton For more information about this report visit http://www.researchandmarkets.com/research/22pnx7/sealants_and Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
News Article | March 1, 2017
Dublin, March 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "5G and Virtual Reality: Emerging Technologies, Solutions, Market Outlook and Forecasts" report to their offering. This research evaluates both the pre-5G VR base market as well as the what we refer to as the 5G Accelerated Uptake market in post-5G era. The report provides forecasting for VR by segments, applications, and regions including revenue forecasts for the period of 2021 - 2026. The report also forecasts VR shipment units and active users for the same period. Virtual Reality (VR) technology and applications will undergo a substantial transformation during the pre-5G era, leading to mass adoption of full featured, mobile supported, and fully immersive VR technologies in post-5G era starting 2020 (along with the commercial deployment of 5G). 5G is expected to reduce network latency significantly, which will enable many previously tethered-only applications and services such as streaming 4K video, real-time remote control, haptic or tactile communications, and more. Coupled with the deployment of gigabit Ethernet fiber, 5G will transform the VR market, leading to a fully immersive experience with haptic capabilities becoming imbedded in many applications. Key Findings: - The base market for VR will reach 978M users by 2026 - The accelerated update due to 5G will lead to $72B revenue by 2026 - The combination of gigabit Ethernet and 5G to catapult VR penetration - Semiconductor components will lead the H/W market with 40% market share - Consumer VR apps to maintain a substantial lead over enterprise and industrial Report Benefits: - Forecasts for base VR and post-5G VR market - Understand how 5G will impact VR apps and services - Identify opportunities for VR across industry verticals - Recognize the impact of untethered VR apps and services - Identify leading technologies and Apps benefitting from 5G VR - Identify leading VR component, solution, app, and service providers Target Audience: - Broadband suppliers - Virtual reality companies - Electronics manufacturers - Network service providers - Regulatory and policy groups - Artificial intelligence providers - Application and content providers Key Topics Covered: 1 Executive Summary 2 Introduction and 5G Contribution to VR 2.1 VR Acceleration Curve: Experiment to Experience 2.2 5G Promises to VR Application 2.2.1 Wireless Network Requirement Parameters for VR 2.2.2 Capacitive Sensing and Touch Sensor Technology 2.3 Proliferation of Full Feature Device and Mixed Reality 2.4 Emergence of Eyewear VR Devices 2.5 VR to be Immersive Social Communication Platform 2.6 360 video VR experience will Play Pivotal Role 2.7 Real Time VR will Kick-off the Market 2.8 5G to Allow Full HD Streaming and 4K Video for VR 2.9 5G to Take Haptic Experience Mainstream in VR Application 2.10 5G to allow Network Operators to Play Pivotal Role into VR Ecosystem 2.11 5G to Support Drone and Telerobotic into VR Ecosystem 2.12 Chip Manufacturer to Play Important Role 2.13 Increasing role of VR Service Players 2.14 Wider adoption of VR Application in Diverse Sectors including Government & Public Sector 2.15 Virtual Privacy and Criminality will be New Battle Ground 3 VR Ecosystem in Post-5G Era 4 VR Market Outlook in Post-5G Era 4.1 Global VR Base Market 4.1.1 Combined Market Revenue 2021 - 2026 4.1.2 Combined Unit Shipment 2021 - 2026 4.1.3 Combined Active User 2021 - 2026 4.2 5G Accelerated VR Uptake Market 4.2.1 Market by Segments 2021 - 2026 188.8.131.52 Hardware Market 184.108.40.206.1 Full Feature Device including Haptic & Eyewear Devices 220.127.116.11.2 Hardware Components including Haptic Sensors & Semiconductor Components 18.104.22.168 Software & Application Market 22.214.171.124 Professional Service Market 4.2.2 VR Shipment Units 2021 - 2026 4.2.3 VR Active Users 2021 - 2026 4.2.4 Market by Region 2021 - 2026 126.96.36.199 North America Market 188.8.131.52 APAC Market 184.108.40.206 Europe Market 5 Potential VR Application in Post-5G Era 5.1 Consumer Application Market 2021 - 2026 5.1.1 Gaming 220.127.116.11 Pokemon Go Market Learning 5.1.2 Live Events 5.1.3 Video Entertainment 5.2 Enterprise Application Market 2021 - 2026 5.2.1 Retail Sector 5.2.2 Real Estate 5.2.3 Healthcare 5.2.4 Education 5.3 Industrial Application Market 2021 - 2026 5.3.1 Military 5.3.2 Engineering 5.3.3 Civil Aviation 5.3.4 Medical Industry 5.3.5 Agriculture 5.3.6 Government & Public Sector 6 Company Initiatives and VR Solution Analysis 6.1 Facebook 6.1.1 Social VR with Oculus Rift 6.1.2 Oculus Touch 6.1.3 Telecom Infra Project 6.2 Huawei Technologies 6.2.1 VR Headset 6.2.2 5G Vision and VR Focus 6.3 Qualcomm Inc. 6.4 ZTE Corporation 6.4.1 MEC Solution, Pre5G Capabilities and VR 6.5 Samsung Electronics 6.5.1 Gear VR, Milk VR and Project Beyond 6.6 Google 6.6.1 Google DayDream Platform 6.6.2 Expeditions 6.7 SK Telecom 6.8 LG Corporation 6.9 Nokia StarGazing VR Application 6.10 VREAL 6.11 Microsoft Corporation 6.11.1 HoloLens 6.12 Vuzix Corporation 6.12.1 Wearable Display Products 6.13 Cyber Glove Systems 6.13.1 Data Gloves Solution 6.13.2 Haptic Workstation 6.13.3 VR Software 6.14 Leap Motion, Inc. 6.14.1 Gesture Controller 6.14.2 Orion Software 6.15 Sensics, Inc. 6.15.1 VR Component and Product 6.15.2 OSVR Platform 6.16 Sixense Entertainment, Inc. 6.16.1 Sixense STEM 6.16.2 Sixense MakeVR 6.17 OSVR Platform 6.18 Intel Corporation 6.18.1 Project Alloy 6.19 Alcatel 6.19.1 VISION 6.19.2 360 Camera 6.20 Nvidia Corporation 6.20.1 VRWorks 6.21 BARCO 6.22 NGRAIN 6.23 StreamVR Platform 6.24 Analog Devices Inc. 6.25 Atmel Corporation 6.26 Cypress Semiconductor Corp 6.27 NXP 6.27.1 Acquisition of Freescale Semiconductor 6.28 Integrated Device Technology Inc 6.29 Maxim Integrated 6.30 NKK Switches 6.31 Rohm Semiconductor 6.32 Semtech Corporation 6.33 Texas Instruments 7 Conclusions and Market Recommendations 7.1 Recommendations for VR Market Players 7.2 Recommendations for Investment Community Companies Mentioned - 1 Project Alloy - 1 Sixense STEM - 1 VISION - 2 360 Camera - 2 Sixense MakeVR - Alcatel - Analog Devices Inc. - Atmel Corporation - BARCO - Cyber Glove Systems - Cypress Semiconductor Corp - Facebook - Google - Huawei Technologies - Integrated Device Technology Inc - Intel Corporation - LG Corporation - Leap Motion, Inc. - Maxim Integrated - Microsoft Corporation - NGRAIN - NKK Switches - NXP - Nokia StarGazing VR Application - Nvidia Corporation - OSVR Platform - Qualcomm Inc. - Rohm Semiconductor - SK Telecom - Samsung Electronics - Semtech Corporation - Sensics, Inc. - Sixense Entertainment, Inc. - StreamVR Platform - Texas Instruments - VREAL - Vuzix Corporation - ZTE Corporation For more information about this report visit http://www.researchandmarkets.com/research/vklrpq/5g_and_virtual
News Article | February 16, 2017
BASEL, Switzerland and WATERTOWN, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Lonza Houston, Inc., a global leader in viral gene and cell therapy manufacturing, and Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on developing biologic therapies for rare and serious diseases that avoid unwanted immunogenicity, have entered into a strategic manufacturing agreement. Under the terms of the agreement, Lonza will produce an Anc80-AAV-based gene therapy product for Selecta’s proprietary program for the treatment of Methylmalonic Acidemia (MMA), a rare inborn error of metabolism, and may in the future produce other Anc80-based products for which Selecta holds exclusive options. This relationship will leverage Lonza’s expertise in the development of robust and industry-scale manufacturing platforms for viral-based products. Data shows that Anc80-AAV, an in silico-designed synthetic gene therapy vector, has the potential to provide superior gene expression levels in retina, liver, muscle, cochlea’s outer hair cells and other tissue targets in preclinical studies, as well as reduced cross-reactivity as compared to naturally occurring adeno-associated viral vectors (AAVs) that are currently in clinical development. “This agreement with Selecta Biosciences continues to demonstrate Lonza’s leadership position in the cell and gene therapy space,” said Andreas Weiler, Ph.D., Head of Emerging Technologies Business Unit for Lonza’s Pharma&Biotech segment. “Lonza will utilize our extensive cGMP manufacturing knowledge and world-class quality systems to help Selecta Biosciences develop promising novel therapeutics for patients impacted by MMA and other devastating diseases.” “We at Selecta are focused on combining novel and proprietary viral vectors with our immune tolerance Synthetic Vaccine Particles (SVP™) to enable the first non-immunogenic gene therapies, providing the potential for repeat dosing,” said Werner Cautreels, Ph.D., Selecta’s president, CEO and chairman. “We view Lonza – one of the industry’s largest contract manufacturers of biologics and a leading supplier in gene therapy – as an ideal partner. They already have invested in developing various expression technologies, and they share our excitement about Anc80. We look forward to working with them to bring the first Anc80-based program into the clinic as a potential treatment for patients afflicted with MMA.” MMA is an inborn error of metabolism that, according to the National Institutes of Health (NIH), affects an estimated one in 25,000 to 48,000 individuals globally. MMA patients are unable to process certain proteins and fats, leading to the accumulation of toxic metabolites. Symptoms start to develop in early childhood and, despite strict diet, patients suffer from a wide range of disease-related complications such as pancreatitis, strokes and chronic kidney failure. Selecta exclusively licensed Anc80 for MMA from Massachusetts Eye and Ear® (MEE) in May 2016. Under the license agreement, Selecta also has the exclusive option to develop gene therapies using Anc80 for additional pre-defined lysosomal storage, genetic muscular and genetic metabolic diseases. Selecta intends to combine Anc80 with recently discovered transgenes and Selecta’s SVP-Rapamycin to create a novel gene therapy candidate for MMA. This candidate is intended to a) enable the treatment of patients with and without pre-existing anti-AAV antibodies; b) prevent cellular immune responses that often reduce the expression levels of gene therapies; and c) provide the ability to administer repeat gene therapy doses to achieve sufficient levels of methylmalonyl-CoA mutase (MUT), the enzyme that MMA patients are lacking. To advance the MMA program, Selecta entered into a Collaborative Research and Development Agreement (CRADA) with MEE and the National Human Genome Research Institute, NIH, in 2016. Principal investigators in this CRADA initiative are Charles Venditti, MD, PhD, Senior Investigator and Head, Organic Acid Research Section, Medical Genomics and Metabolic Genetics Branch and Luk Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at MEE and an Assistant Professor at Harvard Medical School. A physician-scientist specializing in the study of inborn errors of metabolism including MMA, Dr. Venditti and his group have published several studies showing the effectiveness of gene therapy as a treatment for MMA in mice. Dr. Vandenberghe from MEE is the inventor of Anc80. Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. It harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only is Lonza a custom manufacturer and developer, the company also offers services and products ranging from active pharmaceutical ingredients to drinking water sanitizers, from nutritional and personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with approximately 40 major manufacturing and R&D facilities and more than 10,000 full-time employees worldwide. The company generated sales of CHF 4.13 billion in 2016 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com. Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing biologic therapies for rare and serious diseases that avoid the immune responses that compromise efficacy and lead to life-threatening complications. Selecta is applying its proprietary Synthetic Vaccine Particles (SVP™) to a range of therapeutic areas in which immunogenicity is a key challenge. SEL-212, the company’s lead candidate in Phase 2, is being developed to treat chronic refractory gout patients and reduce their debilitating symptoms, including flares and inflammatory arthritis. Further, Selecta’s two proprietary gene therapy product candidates have the unique potential to enable repeat administration, allowing for dose adjustment in patients and maintenance of therapeutic activity over time. The company is seeking to expand the use of its SVP platform in other areas, such as immuno-oncology, allergies, autoimmune diseases and vaccines. Selecta is based in Watertown, Massachusetts. For more information, please visit http://selectabio.com. Additional Lonza Information and Disclaimer Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual. Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this presentation due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this release. Selecta Biosciences, Inc. Disclaimer Any statements in this press release about the future expectations, plans and prospects of Selecta Biosciences, Inc. (“the company”), including without limitation, statements regarding the development of its pipeline, the ability of the company’s SVP platform, including SVP-Rapamycin, to mitigate immune response and create better therapeutic outcomes, the potential treatment applications for products utilizing the SVP platform in areas such as gene therapy, immuno-oncology, allergies, autoimmune diseases and vaccines, whether the company’s proprietary gene therapy product candidates will enable repeat administration, allow for dose adjustment in patients or maintain therapeutic activity over time, the sufficiency of the company’s cash, cash equivalents, investments, and restricted cash and other statements containing the words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “hypothesize,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “would,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, the following: the uncertainties inherent in the initiation, completion and cost of clinical trials including their uncertain outcomes, the unproven approach of the company’s SVP technology, undesirable side effects of the company’s product candidates, its reliance on third parties to manufacture its product candidates and to conduct its clinical trials, the company’s inability to maintain its existing or future collaborations, licenses or contractual relationships, its inability to protect its proprietary technology and intellectual property, potential delays in regulatory approvals, the availability of funding sufficient for its foreseeable and unforeseeable operating expenses and capital expenditure requirements, substantial fluctuation in the price of its common stock, a significant portion of the company’s total outstanding shares have recently become eligible to be sold into the market, and other important factors discussed in the “Risk Factors” section of the company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, or SEC, on November 10, 2016, and in other filings that the company makes with the SEC. In addition, any forward-looking statements included in this press release represent the company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The company specifically disclaims any obligation to update any forward-looking statements included in this press release.